Loading clinical trials...
Loading clinical trials...
This study evaluates how synthetic cooling additives like WS-3 and WS-23 impact e-cigarette perceptions, use behavior, and toxicant exposure.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Collaborators
NCT07226986 · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
NCT07207408 · Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
NCT07048405 · Brown Adipose Tissue, Cold Exposure, and more
NCT07044297 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT00404898 · Exposure to World Trade Center Dust
Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions